Roche Holding AG (RHHBY)
Roche Market Cap: 209.26B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 209.26B |
May 16, 2024 | 208.24B |
May 15, 2024 | 200.27B |
May 14, 2024 | 197.40B |
May 13, 2024 | 193.57B |
May 10, 2024 | 197.40B |
May 09, 2024 | 197.08B |
May 08, 2024 | 194.02B |
May 07, 2024 | 194.40B |
May 06, 2024 | 191.91B |
May 03, 2024 | 190.25B |
May 02, 2024 | 186.62B |
May 01, 2024 | 189.74B |
April 30, 2024 | 190.19B |
April 29, 2024 | 193.44B |
April 26, 2024 | 192.93B |
April 25, 2024 | 191.47B |
April 24, 2024 | 194.78B |
April 23, 2024 | 199.25B |
April 22, 2024 | 197.14B |
April 19, 2024 | 193.95B |
April 18, 2024 | 191.66B |
April 17, 2024 | 191.85B |
April 16, 2024 | 192.80B |
April 15, 2024 | 195.04B |
Date | Value |
---|---|
April 12, 2024 | 195.10B |
April 11, 2024 | 197.46B |
April 10, 2024 | 195.10B |
April 09, 2024 | 195.55B |
April 08, 2024 | 192.55B |
April 05, 2024 | 192.87B |
April 04, 2024 | 196.12B |
April 03, 2024 | 199.63B |
April 02, 2024 | 200.14B |
April 01, 2024 | 203.78B |
March 28, 2024 | 203.58B |
March 27, 2024 | 199.69B |
March 26, 2024 | 199.69B |
March 25, 2024 | 199.57B |
March 22, 2024 | 199.76B |
March 21, 2024 | 199.76B |
March 20, 2024 | 208.05B |
March 19, 2024 | 204.86B |
March 18, 2024 | 205.24B |
March 15, 2024 | 208.18B |
March 14, 2024 | 209.77B |
March 13, 2024 | 218.25B |
March 12, 2024 | 224.18B |
March 11, 2024 | 220.74B |
March 08, 2024 | 216.21B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Novartis AG | 209.28B |
Pfizer Inc | 162.29B |
ADC Therapeutics SA | 394.53M |
Lonza Group Ltd | 41.89B |
Sarepta Therapeutics Inc | 12.42B |
Market Cap Related Metrics
PE Ratio | 16.40 |
PS Ratio | 3.116 |
Price to Book Value | 5.996 |
Price to Free Cash Flow | 16.46 |
Price | 32.81 |
Earnings Yield | 6.10% |
Operating PE Ratio | 12.26 |
Normalized PE Ratio | 16.21 |